1. Home
  2. FLGT vs SPTN Comparison

FLGT vs SPTN Comparison

Compare FLGT & SPTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FLGT
  • SPTN
  • Stock Information
  • Founded
  • FLGT 2011
  • SPTN 1917
  • Country
  • FLGT United States
  • SPTN United States
  • Employees
  • FLGT N/A
  • SPTN N/A
  • Industry
  • FLGT Medical Specialities
  • SPTN Food Distributors
  • Sector
  • FLGT Health Care
  • SPTN Consumer Discretionary
  • Exchange
  • FLGT Nasdaq
  • SPTN Nasdaq
  • Market Cap
  • FLGT 639.0M
  • SPTN 596.4M
  • IPO Year
  • FLGT 2016
  • SPTN N/A
  • Fundamental
  • Price
  • FLGT $19.53
  • SPTN $17.64
  • Analyst Decision
  • FLGT Buy
  • SPTN
  • Analyst Count
  • FLGT 2
  • SPTN 0
  • Target Price
  • FLGT $24.00
  • SPTN N/A
  • AVG Volume (30 Days)
  • FLGT 256.3K
  • SPTN 433.8K
  • Earning Date
  • FLGT 08-01-2025
  • SPTN 08-14-2025
  • Dividend Yield
  • FLGT N/A
  • SPTN 4.99%
  • EPS Growth
  • FLGT N/A
  • SPTN N/A
  • EPS
  • FLGT N/A
  • SPTN N/A
  • Revenue
  • FLGT $292,448,000.00
  • SPTN $9,652,685,000.00
  • Revenue This Year
  • FLGT $11.79
  • SPTN $6.00
  • Revenue Next Year
  • FLGT $10.45
  • SPTN N/A
  • P/E Ratio
  • FLGT N/A
  • SPTN N/A
  • Revenue Growth
  • FLGT 1.71
  • SPTN 0.26
  • 52 Week Low
  • FLGT $14.57
  • SPTN $17.30
  • 52 Week High
  • FLGT $25.11
  • SPTN $23.00
  • Technical
  • Relative Strength Index (RSI)
  • FLGT 40.94
  • SPTN 39.17
  • Support Level
  • FLGT $20.30
  • SPTN $17.59
  • Resistance Level
  • FLGT $21.07
  • SPTN $18.27
  • Average True Range (ATR)
  • FLGT 0.69
  • SPTN 0.55
  • MACD
  • FLGT -0.25
  • SPTN -0.09
  • Stochastic Oscillator
  • FLGT 1.15
  • SPTN 4.59

About FLGT Fulgent Genetics Inc.

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.

About SPTN SpartanNash Company

SpartanNash Co is a food solutions company that delivers the ingredients. Its principal business activities include, distributing grocery products to a diverse group of independent and chain retailers, its corporate-owned retail stores, and U.S. military commissaries and exchanges; as well as operating a fresh produce distribution network and the Our Family private label brand. The company operates in two segments: Retail and Wholesale. Majority of the revenue is earned from its Wholesale segment which uses a multi-channel sales approach to distribute national brand and private brand products to independent retailers, national accounts, food service distributors, e-commerce providers, and the Company's corporate owned retail stores.

Share on Social Networks: